GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sichuan Hebang Biotechnology Co 603077.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

2.04

-0.97%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥7.19bn

FY2016FY2025

Net income

−CN¥536.4m

FY2016FY2025

Free cash flow

−CN¥182.7m

FY2016FY2025

Shareholders' equity

CN¥17.88bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥7.19bnCN¥8.55bnCN¥8.82bnCN¥13.04bnCN¥9.99bnCN¥5.26bnCN¥5.97bnCN¥6.01bnCN¥4.74bnCN¥3.46bn
Research and developmentCN¥17.3mCN¥30.6mCN¥47.3mCN¥67.9mCN¥33.3mCN¥39.7mCN¥38.3mCN¥31.1mCN¥34.8mCN¥28.1m
Operating incomeCN¥266.0m−CN¥50.4mCN¥1.54bnCN¥4.48bnCN¥3.59bnCN¥440.5mCN¥639.4mCN¥468.8mCN¥616.6mCN¥394.4m
Net income−CN¥536.4mCN¥31.5mCN¥1.28bnCN¥3.81bnCN¥3.02bnCN¥40.9mCN¥516.9mCN¥363.1mCN¥517.5mCN¥317.8m
Diluted earnings per share-0.050.000.150.440.360.010.060.040.060.05

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥28.21bnCN¥29.65bnCN¥24.54bnCN¥24.10bnCN¥17.92bnCN¥14.74bnCN¥14.48bnCN¥13.29bnCN¥13.11bnCN¥12.93bn
Cash and short-term investments—CN¥7.00bnCN¥3.06bnCN¥4.59bnCN¥1.77bnCN¥845.9mCN¥796.6mCN¥1.34bnCN¥830.7mCN¥308.7m
Total liabilitiesCN¥10.25bnCN¥10.64bnCN¥4.32bnCN¥4.34bnCN¥3.29bnCN¥3.43bnCN¥3.03bnCN¥2.09bnCN¥1.83bnCN¥2.15bn
DebtCN¥6.11bnCN¥7.30bnCN¥1.62bnCN¥1.82bnCN¥1.37bnCN¥2.15bnCN¥1.86bnCN¥1.16bnCN¥915.5mCN¥1.24bn
Shareholders' equityCN¥17.88bnCN¥18.63bnCN¥19.58bnCN¥19.12bnCN¥14.25bnCN¥11.14bnCN¥11.23bnCN¥10.97bnCN¥10.99bnCN¥10.46bn
Shares outstanding10,334m9,468m8,632m8,725m8,360m8,130m8,370m8,731m8,823m6,897m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.08bnCN¥467.9mCN¥200.8mCN¥2.64bnCN¥3.20bnCN¥368.9mCN¥162.9mCN¥944.4mCN¥176.9mCN¥575.3m
Capital spending−CN¥1.26bn−CN¥1.12bn−CN¥828.7m−CN¥936.2m−CN¥1.74bn−CN¥197.1m−CN¥662.5m−CN¥363.6m−CN¥508.5m−CN¥677.4m
Free cash flow−CN¥182.7m−CN¥648.3m−CN¥628.0mCN¥1.71bnCN¥1.46bnCN¥171.8m−CN¥499.6mCN¥580.8m−CN¥331.6m−CN¥102.2m
Dividends paid−CN¥135.8m−CN¥246.7m−CN¥392.6m−CN¥130.9m−CN¥78.0m−CN¥92.7m−CN¥71.1m−CN¥253.2m−CN¥110.2m−CN¥198.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.50bnCN¥1.39bnCN¥1.26bnCN¥2.01bnCN¥2.20bnCN¥1.73bnCN¥1.73bnCN¥1.97bn
Operating incomeCN¥351.5mCN¥208.1m−CN¥7.4mCN¥137.9mCN¥34.6mCN¥20.9m−CN¥322.1mCN¥14.5m
Net incomeCN¥206.6mCN¥173.6m−CN¥629.5mCN¥41.3mCN¥39.3mCN¥12.5m−CN¥189.9mCN¥29.0m
Diluted earnings per share0.020.02-0.060.000.000.00-0.020.00
Cash from operations———CN¥165.0mCN¥200.0m−CN¥53.0m—−CN¥33.0m
Capital spending−CN¥404.0m−CN¥253.0m−CN¥588.0m−CN¥200.0m−CN¥138.0m−CN¥330.0m−CN¥571.0m−CN¥211.0m
Free cash flow———−CN¥35.0mCN¥62.0m−CN¥383.0m—−CN¥244.0m
Total assetsCN¥29.64bnCN¥28.72bnCN¥28.21bnCN¥29.29bnCN¥29.22bnCN¥29.84bnCN¥29.65bnCN¥25.98bn
Cash and short-term investments———CN¥6.82bnCN¥6.86bnCN¥7.12bnCN¥7.00bnCN¥2.57bn
DebtCN¥7.26bnCN¥6.94bnCN¥6.11bnCN¥2.99bnCN¥8.22bnCN¥8.38bnCN¥7.29bnCN¥2.83bn
Shareholders' equityCN¥19.27bnCN¥18.10bnCN¥17.88bnCN¥18.52bnCN¥18.49bnCN¥18.47bnCN¥18.63bnCN¥18.76bn

Financial ratios

Data as of 24 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin3.7%-0.6%17.5%34.4%36.0%8.4%
Net margin-7.5%0.4%14.5%29.2%30.2%0.8%
Return on equity-3.0%0.2%6.6%19.9%21.2%0.4%
Return on assets-1.9%0.1%5.2%15.8%16.8%0.3%
Free cash flow yield10.2%7.5%5.4%18.5%26.6%3.1%
Revenue growth-15.9%-3.1%-32.3%30.6%89.8%-11.9%
Earnings growth-1804.8%-97.5%-66.3%26.1%7272.5%-92.1%
Current ratio3.18x2.61x2.69x2.60x1.49x1.05x
Debt to equity0.34x0.39x0.08x0.09x0.09x0.19x
Equity ratio63.4%62.8%79.8%79.3%79.5%75.6%
Interest coverage2.12x-0.75x53.84x86.12x45.42x4.81x
R&D as a share of sales0.2%0.4%0.5%0.5%0.3%0.8%
Buybacks as a share of market value-9.2%-9.7%1.1%-4.4%-2.8%2.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-18.0%6.4%9.6%
Operating income-61.0%-9.6%2.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin1.4%16.6%19.4%16.6%
Net margin-3.2%12.2%14.5%12.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-43.5—15.97.09.4282.024.039.034.150.5
Price to sales3.32.32.32.02.92.22.12.43.74.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 15 Oct 2024.

FY2024FY2023FY2022FY2018FY2017FY2016FY2015FY2014
Paid in the year0.020.0450.0150.020.0050.0050.0230.007
  • 3-for-1 split · 2 Sept 2015
  • 2-for-1 split · 11 Jul 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.